Skip to main content
Top

2006 | OriginalPaper | Hoofdstuk

Is er een relatie tussen diabetes mellitus en een cardiomyopathie?

Auteurs : dr. D.J.W. van Kraaij, prof. dr. H.J.G.M. Crijns

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Het is algemeen bekend dat patiënten met diabetes mellitus een zwaar belast cardiovasculair risicoprofiel hebben en dat cardiovasculaire ziekten de belangrijkste bron van morbiditeit en mortaliteit vormen bij patiënten met diabetes mellitus 1, 2. Diverse epidemiologische studies rapporteren een sterke correlatie tussen diabetes mellitus en hartfalen. Mannen met diabetes mellitus hebben twee maal zo vaak hartfalen, vrouwen zelfs vijf maal zo vaak. Diabetes mellitus is bovendien als voorspeller van hartfalen onafhankelijk van leeftijd, bloeddruk, adipositas, hypercholesterolemie of coronairlijden.
Literatuur
go back to reference Garcia MJ, McNamara PM, Kannel WB. Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes 1974; 23: 105-11. Garcia MJ, McNamara PM, Kannel WB. Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes 1974; 23: 105-11.
go back to reference American Diabetes Association, The National Heart, Lung, and Blood Institute, the Juvenile Diabetes Foundation International, the National lnstitute of Diabetes and Digestive and Kidney Disease, the American Heart Assoctation. Diabetes mellitus, a major risk factor tor cardiovascular disease. Circulation 1999; 100: 1132-33. American Diabetes Association, The National Heart, Lung, and Blood Institute, the Juvenile Diabetes Foundation International, the National lnstitute of Diabetes and Digestive and Kidney Disease, the American Heart Assoctation. Diabetes mellitus, a major risk factor tor cardiovascular disease. Circulation 1999; 100: 1132-33.
go back to reference Bauters C, Lamblin N, McFadden EP, Belle E van, Millaire A, Groote P de. Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol 2003; 2: 1. Bauters C, Lamblin N, McFadden EP, Belle E van, Millaire A, Groote P de. Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol 2003; 2: 1.
go back to reference Scognamiglio R, Casara D, Avogaro A. Myocardial dysfunction and adrenergic innervation in patients with type 1 diabetes mellitus. Diabetes Nutr Metab 2000; 13: 346-49. Scognamiglio R, Casara D, Avogaro A. Myocardial dysfunction and adrenergic innervation in patients with type 1 diabetes mellitus. Diabetes Nutr Metab 2000; 13: 346-49.
go back to reference Hoeven KH van, Factor SM. Diabetic heart disease - part II: the clinical and pathological spectrum. Clin Cardiol 1989; 12: 667-71. Hoeven KH van, Factor SM. Diabetic heart disease - part II: the clinical and pathological spectrum. Clin Cardiol 1989; 12: 667-71.
go back to reference Nahser Jr. PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JO. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995; 91: 635-40. Nahser Jr. PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JO. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995; 91: 635-40.
go back to reference Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998; 180: 53-57. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998; 180: 53-57.
go back to reference Choi KM, Zhong Y, Hoit BD, et al. Detective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002; 283 (4): H1398-1408. Choi KM, Zhong Y, Hoit BD, et al. Detective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002; 283 (4): H1398-1408.
go back to reference Sowers JR, Epstein M, Frohlich ED. Diabetes , hypertension, and cardiovascular disease. Hypertension 2001; 37 1053-59. Sowers JR, Epstein M, Frohlich ED. Diabetes , hypertension, and cardiovascular disease. Hypertension 2001; 37 1053-59.
go back to reference Asif M, Egan J, Vasan S, et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA 2000; 97: 2809-13. Asif M, Egan J, Vasan S, et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA 2000; 97: 2809-13.
go back to reference Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-59. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-59.
Metagegevens
Titel
Is er een relatie tussen diabetes mellitus en een cardiomyopathie?
Auteurs
dr. D.J.W. van Kraaij
prof. dr. H.J.G.M. Crijns
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_14